PS
NVRO

Principal Securities’s NEVRO CORP. NVRO Stock Holding History

Principal Securities’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-112
Closed -$943 – 3560
2024
Q2 		$943 Hold
112
– – ﹤0.01% 3083
2024
Q1 		$1.62K Sell
112
-92
-45% -$1.52K ﹤0.01% 2931
2023
Q4 		$4.39K Buy
+204
New +$3.64K ﹤0.01% 2573

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Principal Securities's NVRO Position: Q3 2024 in Review

Principal Securities sold out of NEVRO CORP. (NVRO) in Q3 2024, closing a stake of 112 shares — an estimated $943 sold.

Principal Securities first reported a position in NVRO in Q4 2023 and held it in 3 quarters. The position peaked at $4.39K in Q4 2023. 131 funds tracked by Wall St. Rank hold NVRO as of Q3 2024.

  • Principal Securities reported no remaining NEVRO CORP. position as of Q3 2024 after selling out during the quarter.
  • Principal Securities sold 112 NEVRO CORP. shares in Q3 2024, an estimated $943.
  • Principal Securities first reported a position in NEVRO CORP. in Q4 2023 and held it in 3 quarters.
  • Principal Securities's NEVRO CORP. position peaked at $4.39K in Q4 2023.
  • 131 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2024.

Based on Principal Securities's 13F filing for Q3 2024, filed 28 Oct 2024.